Pharmafile Logo

Recognizing C diff Awareness Month in 2024

- PMLiVE

Every year, the medical community recognizes the month of November as Clostridioides difficile (C. diff) Awareness month. C. diff is a public health threat that causes around 500,000 infections every year, leading to diarrhea and colitis in patients who become infected. C. diff Awareness Month is meant to raise awareness for patients and clinicians on the risk factors, diagnosis, prevention, and treatment of this debilitating disease. All month long, resources such as fact sheets, patient experiences, and more are made available and promoted by leaders in infectious disease and public health.

The Peggy Lillis Foundation is among those leaders, working to advocate and educate on C diff to work toward a world where the infection is treatable and survivable. Since 2023, Medscape has partnered with the Peggy Lillis Foundation to create education that keeps clinicians on the cutting-edge of C diff prevention and treatment. As part of this partnership, Medscape recognizes C diff Awareness Month through social media and other engagements.  

Medscape’s 2023 C diff awareness campaign saw over 1.4 million engagements on social media, including for a livestreamed education event featuring experts from the Peggy Lillis Foundation. The overall campaign featured insights from clinicians and leaders in C diff advocacy, videos with updated information, and facts that could be easily shared on and off social media. Videos on C diff, posted on Medscape’s social media accounts, were viewed more than 10,000 times. 

“We’re proud to work with such a great organization as the Peggy Lillis Foundation. Our campaign during November 2023 was highly successful, and we’re looking forward to doing even more now in 2024. Together, we share the vision of a world where C diff is preventable and rare, and our efforts toward that goal are making a difference,” said Catherine C Capparelli, MBA, CHCP, Senior Director, Strategic Partnerships. 

For more information on education on C diff or infectious diseases, please contact Jess Dropkin at JDropkin@Medscape.net. 

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

The Need for and Impact of Rare Disease Education

Physicians are often told that when they hear hoofbeats, think horses, not zebras — to look for the most common cause of a patient’s symptoms first. While this advice may...

Medscape Education: Rare Diseases Fibrodysplasia Ossificans Progressiva

Rare Disease Day is on February 28.Listen to Nicky explain her daughter's journey with fibrodysplasia ossificans progressiva.Many patients face long waits for accurate diagnosis and treatment, making it critically important...

Medscape Education: Rare Diseases

It's only a few days until #RareDiseaseDay2023 on 28th February. We're taking a patient centered approach, this means understanding their journey so we can better understand how we can help to...

Together Caring for Rare Disease

Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...

Medscape Education Wins Best Practice Award for Learner Outcomes at NAMEC

This year's winners have been announced  for the National Association of Medical Education Companies (NAMEC) awards. These awards recognize best practices-ideas or processes that can be implemented by NAMEC members to...

Medscape Education and Medics4RareDisease Uncover the Education Gaps in Their Compelling Rare Disease Day Campaign

Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...

What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?

Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS...

DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE

During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...

ESMO’s New Focus on Cancer Prevention

During ESMO 2022 in Paris, John Whyte, chief medical officer at WebMD was joined by Fabrice André, MD, PhD, Chair of the scientific committee at the European Society for Medical Oncology (ESMO),...

ESMO Patient Centricity – Highlights from Steve Clark

During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK),...